Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Anmbreen Jamroze"'
Autor:
Fengzhi Li, Xiang Ling, Sayan Chakraborty, Christos Fountzilas, Jianmin Wang, Anmbreen Jamroze, Xiaozhuo Liu, Pawel Kalinski, Dean G. Tang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-26 (2023)
Abstract There is increasing evidence indicating the significant role of DDX5 (also called p68), acting as a master regulator and a potential biomarker and target, in tumorigenesis, proliferation, metastasis and treatment resistance for cancer therap
Externí odkaz:
https://doaj.org/article/30e67990699f4a9691fd82d5b47de1b1
Autor:
Arsheed A. Ganaie, Aijaz Parray, Tabish Hussain, Ashraf Shabaneh, Anmbreen Jamroze, Marina G. Ferrari, Lei Wang, D. Joshua Liao, Shahriar Koochekpour, Sanjeev Nanda, Jinhua Wang, Yibin Deng, Sergio A Gradilone, Edward H. Hinchcliffe, Badrinath R. Konety, Mohammad Saleem
Publikováno v:
Translational Oncology, Vol 12, Iss 8, Pp 1056-1071 (2019)
Therapy failure and metastasis-associated mortality are stumbling blocks in the management of PDAC in patients. Failure of therapy is associated to intense hypoxic conditions of tumors. To develop effective therapies, a complete understanding of hypo
Externí odkaz:
https://doaj.org/article/8b84d9c2c20e45bc9e8e04634c0dff6a
Autor:
Mohammad Saleem, Badrinath R. Konety, Eva Corey, Colm Morrissey, Paari Murugan, Firdous H. Beigh, Raihana Maqbool, Marina G. Ferrari, Arsheed A. Ganaie, Adrian P. Mansini, Anmbreen Jamroze, Mudassir Meraj Banday, Syed Umbreen
Supplementary Data showing (i) expression of COMMD3 in PDX models and (ii) association of MYC to COMMD3 in prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94b8280bae0526c5a0e3ca73d5aa7376
https://doi.org/10.1158/1535-7163.22510041
https://doi.org/10.1158/1535-7163.22510041
Publikováno v:
Cancer Research. 83:2601-2601
LRIG1, leucine-rich repeats and immunoglobulin-like domains protein 1, is deleted or downregulated in many cancer types and has been reported to function as a tumor suppressor. LRIG1 is preferentially expressed in adult stem/progenitor cells and regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::938ced482c84f77e003983b94521f54e
https://doi.org/10.1158/1538-7445.am2023-2601
https://doi.org/10.1158/1538-7445.am2023-2601
Autor:
Stuthi Perimbeti, Anmbreen Jamroze, Kristopher Attwood, Bailey Farmer, Jan Hendrik Beumer, Robert Bies, Ellis Glenn Levine, Jason Kirk, Dean Tang, Gurkamal S. Chatta, Dharmesh Gopalakrishnan
Publikováno v:
Journal of Clinical Oncology. 41:182-182
182 Background: Androgen receptor (AR) signaling is critical to prostate cancer (PCa) cell survival and proliferation. Androgen ablation leads to expansion of both AR−/lo and AR+/hi resistant clones in CRPC xenografts. Most current therapies for mC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a20edf33d3bb6a07d6367b91c5105f3
https://doi.org/10.1200/jco.2023.41.6_suppl.182
https://doi.org/10.1200/jco.2023.41.6_suppl.182
Publikováno v:
Cancer Lett
Androgen receptor (AR), a ligand-dependent nuclear transcription factor and a member of steroid hormone receptor family, plays an important role in prostate organogenesis by regulating epithelial differentiation and restricting cell proliferation. Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17992ead6a51c14be59f5ebbfca7a7e4
https://europepmc.org/articles/PMC8355210/
https://europepmc.org/articles/PMC8355210/
Autor:
Arsheed A. Ganaie, Mohammad Saleem, Badrinath R. Konety, Paari Murugan, Syed Umbreen, Adrian P. Mansini, Anmbreen Jamroze, Marina G. Ferrari, Raihana Maqbool, Colm Morrissey, Mudassir M. Banday, Firdous H. Beigh, Eva Corey
Publikováno v:
Molecular Cancer Therapeutics. 18:2111-2123
Gene rearrangement is reported to be associated to the aggressive phenotype and poor prognosis in prostate cancer. We identified a gene fusion between a transcription repressor (BMI1) and transcriptional factor (COMMD3) in human prostate cancer. We s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b589f0008588a0fb0cc4e008ed43bfc
https://doi.org/10.1158/1535-7163.mct-19-0150
https://doi.org/10.1158/1535-7163.mct-19-0150
Autor:
Edward H. Hinchcliffe, Tabish Hussain, Marina G. Ferrari, Shahriar Koochekpour, Anmbreen Jamroze, Arsheed A. Ganaie, Sergio A. Gradilone, Aijaz Parray, Lei Wang, Sanjeev Nanda, D. Joshua Liao, Ashraf Shabaneh, Yibin Deng, Jinhua Wang, Badrinath R. Konety, Mohammad Saleem
Publikováno v:
Translational Oncology, Vol 12, Iss 8, Pp 1056-1071 (2019)
Translational Oncology
Translational Oncology
Therapy failure and metastasis-associated mortality are stumbling blocks in the management of PDAC in patients. Failure of therapy is associated to intense hypoxic conditions of tumors. To develop effective therapies, a complete understanding of hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83b809d8d12d3ffe1188e4f5da50a8e4
https://doi.org/10.1016/j.tranon.2019.05.002
https://doi.org/10.1016/j.tranon.2019.05.002
Autor:
Naeem Rashid, Mosè Rossi, Muhammad Akhtar, Maria Ciaramella, Giuseppe Perugino, Anmbreen Jamroze, Anna Valenti
Publikováno v:
Journal of Biological Chemistry. 289:3231-3243
Reverse gyrase is a DNA topoisomerase specific for hyperthermophilic bacteria and archaea. It catalyzes the peculiar ATP-dependent DNA-positive supercoiling reaction and might be involved in the physiological adaptation to high growth temperature. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6966b2ecb53afbb83dd18dfc84abc7cd
https://doi.org/10.1074/jbc.m113.517649
https://doi.org/10.1074/jbc.m113.517649
Publikováno v:
Clinical Cancer Research. 25:TMIM-064
In our previous research we characterized novel ALDH1A inhibitors (1A1, 1A2, 1A3) 673A that specifically target Ovarian Cancer Stem cells (OvCSC) and trigger cell programmed necrosis (necroptosis). Following ALDH1A inhibition CD133+ (A2780) FACS sort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763f6bf2acc8f90344ef92fb69737fce
https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-064
https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-064